|
|
||||||||
1 Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan 606-8507; 2 Hypertension Research Laboratory, National Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka, Japan 565-8565; and 3 Department of Anesthesiology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan 606-8507
Cardiotrophin-1
(CT-1), a member of the interleukin-6 superfamily of cytokines,
possesses hypertrophic actions and atrial natriuretic peptide
(ANP)-producing activity in vitro. The goal of our study is to
elucidate whether CT-1 affects the cardiovascular system in vivo.
Intravenous injection of CT-1 (4-100 µg/kg) in conscious rats
evoked significant declines in blood pressure and reflex increases in
heart rate (HR) in a dose-dependent manner. CT-1 induced no significant
change in cardiac output (from 260.7 ± 11.0 to 264.7 ± 26.6 ml · min
1 · kg
1,
P = not significant), which was compatible with the results from isolated perfused rat hearts; HR, change in pressure over time, left ventricular developed pressure, and perfusion pressure were
unaffected. Northern blot and RT-PCR analyses revealed that CT-1
increased expression of inducible nitric oxide synthase (iNOS) in lung
and aorta but not in heart or liver. Pretreatment with aminoguanidine,
a specific iNOS inhibitor, inhibited both iNOS mRNA production and the
depressor effect of CT-1. Interestingly, CT-1 increased ventricular
expression of ANP and brain natriuretic peptide (BNP). The data
demonstrate that CT-1 elicits its hypotensive effect via a nitric
oxide-dependent mechanism and that CT-1 induces ANP and BNP mRNA
expression in vivo.
blood pressure; nitric oxide synthase; natriuretic peptide
This article has been cited by other articles:
![]() |
D. H. Damon TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3 Am J Physiol Cell Physiol, January 1, 2008; 294(1): C306 - C312. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Clerico, F. A. Recchia, C. Passino, and M. Emdin Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H17 - H29. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hamanaka, Y. Saito, H. Yasukawa, I. Kishimoto, K. Kuwahara, Y. Miyamoto, M. Harada, E. Ogawa, N. Kajiyama, N. Takahashi, et al. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 Is Involved in gp130 Resistance in Cardiovascular System in Rat Treated With Cardiotrophin-1 In Vivo Circ. Res., April 13, 2001; 88(7): 727 - 732. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |